Neurocrine Biosciences Appoints Andrew Ratz as Chief Technical Operations Officer
Neurocrine Biosciences announced the promotion of Andrew Ratz, Ph.D., to the executive management team as the Chief Technical Operations Officer. In his new role, Ratz will lead the company's global technical development, manufacturing, and supply chain functions, supporting Neurocrine's expansion beyond small molecules into biologics and device-based therapies. Ratz joined Neurocrine in January 2025 as senior VP of Drug Development, Delivery and Device, and previously spent nearly 30 years as an executive at Eli Lilly and Company.
